The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth

What is it about?

Hybrid closed-loop therapy links an insulin pump and continuous glucose monitor with an algorithm to automatically help control blood glucose for people with type 1 diabetes. However, the high cost of hybrid closed-loop systems may restrict access. We therefore completed an economic evaluation and found that hybrid closed-loop therapy was likely to be cost-effective compared to current care in Australia among young people with type 1 diabetes.

Featured Image